Literature DB >> 10508032

Prevalence of antimicrobial resistance in respiratory tract isolates of Streptococcus pneumoniae: results of a Canadian national surveillance study. The Canadian Respiratory Infection Study Group.

G G Zhanel1, J A Karlowsky, L Palatnick, L Vercaigne, D E Low, D J Hoban.   

Abstract

From October 1997 to November 1998, 1,180 respiratory tract isolates of Streptococcus pneumoniae were collected from 18 medical centers in 9 of the 10 Canadian provinces. Penicillin-intermediate and -resistant isolates occurred at rates of 14.8 and 6.4%, respectively, and these rates varied considerably by geographic region. Trimethoprim-sulfamethoxazole, tetracycline, and macrolide rates of nonsusceptibility were 12.2, 10.6, and 8.0 to 9.3%, respectively. The most potent agents studied were newer fluoroquinolones.

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10508032      PMCID： PMC89508          DOI： 10.1128/AAC.43.10.2504

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  8 in total

1.  A cross-Canada surveillance of antimicrobial resistance in respiratory tract pathogens.

Authors:  R J Davidson; D E Low
Journal:  Can J Infect Dis       Date:  1999-03

2.  Prevalence of antimicrobial resistance among respiratory tract isolates of Streptococcus pneumoniae in North America: 1997 results from the SENTRY antimicrobial surveillance program.

Authors:  G V Doern; M A Pfaller; K Kugler; J Freeman; R N Jones
Journal:  Clin Infect Dis       Date:  1998-10       Impact factor: 9.079

3.  Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients in the United States during the winter months of 1994 to 1995: results of a 30-center national surveillance study.

Authors:  G V Doern; A Brueggemann; H P Holley; A M Rauch
Journal:  Antimicrob Agents Chemother       Date:  1996-05       Impact factor: 5.191

4.  Surveillance of invasive Streptococcus pneumoniae infection in Quebec, Canada, from 1984 to 1986: serotype distribution, antimicrobial susceptibility, and clinical characteristics.

Authors:  L P Jetté; F Lamothe
Journal:  J Clin Microbiol       Date:  1989-01       Impact factor: 5.948

5.  Canadian national survey of prevalence of antimicrobial resistance among clinical isolates of Streptococcus pneumoniae. Canadian Bacterial Surveillance Network.

Authors:  A E Simor; M Louie; D E Low
Journal:  Antimicrob Agents Chemother       Date:  1996-09       Impact factor: 5.191

6.  Detection and prevalence of pneumococci with increased resistance to penicillin.

Authors:  J M Dixon; A E Lipinski; M E Graham
Journal:  Can Med Assoc J       Date:  1977-11-19       Impact factor: 8.262

7.  Comparative in vitro activities of several new fluoroquinolones and beta-lactam antimicrobial agents against community isolates of Streptococcus pneumoniae.

Authors:  T Mazzulli; A E Simor; R Jaeger; S Fuller; D E Low
Journal:  Antimicrob Agents Chemother       Date:  1990-03       Impact factor: 5.191

8.  Emergence of penicillin-resistant Streptococcus pneumoniae--southern Ontario, Canada, 1993-1994.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1995-03-24       Impact factor: 17.586
  8 in total
  24 in total

1.  Influence of Pharmacokinetic and Pharmacodynamic Principles on Antibiotic Selection.

Authors:  George G. Zhanel
Journal:  Curr Infect Dis Rep       Date:  2001-02       Impact factor: 3.725

2.  Macrolide and fluoroquinolone (levofloxacin) resistances among Streptococcus pneumoniae strains: significant trends from the SENTRY Antimicrobial Surveillance Program (North America, 1997-1999).

Authors:  R N Jones; M A Pfaller
Journal:  J Clin Microbiol       Date:  2000-11       Impact factor: 5.948

3.  Assumed versus approved breakpoints.

Authors:  D A Preston; M R Turnak
Journal:  Antimicrob Agents Chemother       Date:  2000-11       Impact factor: 5.191

4.  Impact of Antimicrobial Resistance on the Treatment of Invasive Pneumococcal Infections.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-10       Impact factor: 3.725

5.  Trends in ciprofloxacin nonsusceptibility and levofloxacin resistance among Streptococcus pneumoniae isolates in North America.

Authors:  J A Karlowsky; L Nealy; D F Sahm; C Thornsberry; M E Jones
Journal:  J Clin Microbiol       Date:  2001-07       Impact factor: 5.948

6.  National surveillance programme on susceptibility patterns of respiratory pathogens in South Africa: moxifloxacin compared with eight other antimicrobial agents.

Authors:  L D Liebowitz; M Slabbert; A Huisamen
Journal:  J Clin Pathol       Date:  2003-05       Impact factor: 3.411

Review 7.  Review of macrolides and ketolides: focus on respiratory tract infections.

Authors:  G G Zhanel; M Dueck; D J Hoban; L M Vercaigne; J M Embil; A S Gin; J A Karlowsky
Journal:  Drugs       Date:  2001       Impact factor: 9.546

8.  Macrolide-resistant Streptococcus pneumoniae in Canada during 1998-1999: prevalence of mef(A) and erm(B) and susceptibilities to ketolides.

Authors:  D J Hoban; A K Wierzbowski; K Nichol; G G Zhanel
Journal:  Antimicrob Agents Chemother       Date:  2001-07       Impact factor: 5.191

9.  Penicillin-binding protein 1A, 2B, and 2X alterations in Canadian isolates of penicillin-resistant Streptococcus pneumoniae.

Authors:  Kimberly A Nichol; George G Zhanel; Daryl J Hoban
Journal:  Antimicrob Agents Chemother       Date:  2002-10       Impact factor: 5.191

10.  Antibiotics for lower respiratory tract infections. Still too frequently prescribed?

Authors:  Warren J McIsaac; Teresa To
Journal:  Can Fam Physician       Date:  2004-04       Impact factor: 3.275
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.